314 related articles for article (PubMed ID: 30103438)
1. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
2. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dipeptidyl peptidase activity by flavonol glycosides of guava (Psidium guajava L.): a key to the beneficial effects of guava in type II diabetes mellitus.
Eidenberger T; Selg M; Krennhuber K
Fitoterapia; 2013 Sep; 89():74-9. PubMed ID: 23707747
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
5. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
[TBL] [Abstract][Full Text] [Related]
6. Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands.
Pantaleão SQ; Philot EA; de Resende-Lara PT; Lima AN; Perahia D; Miteva MA; Scott AL; Honorio KM
Molecules; 2018 Feb; 23(2):. PubMed ID: 29473857
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors.
Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D
Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185
[TBL] [Abstract][Full Text] [Related]
8. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV.
Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL
Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066
[TBL] [Abstract][Full Text] [Related]
9. An Update on Dipeptidyl Peptidase-IV Inhibiting Peptides.
Sivaraman SA; Sabareesh V
Curr Protein Pept Sci; 2024; 25(4):267-285. PubMed ID: 38173201
[TBL] [Abstract][Full Text] [Related]
10. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
Mohanty IR; Borde M; Kumar C S; Maheshwari U
Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
[TBL] [Abstract][Full Text] [Related]
13. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
Ma HH; Zhang J; Li CQ; Zou LW
Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
[TBL] [Abstract][Full Text] [Related]
15. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones.
Amini Z; Fatemi MH; Gharaghani S
Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
17. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Neumiller JJ
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
[TBL] [Abstract][Full Text] [Related]
18. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
[No Abstract] [Full Text] [Related]
20.
Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM
Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
